Evidence map›Paper›PMID 23754630›Full record

ArticleInternational journal of cancer2013

Association between circulating concentrations of 25(OH)D and colorectal adenoma: a pooled analysis.

Elizabeth T Jacobs, Elizabeth A Hibler, Peter Lance, Christine L Sardo, Peter W Jurutka

Abstract read
In one paragraph

Article in International journal of cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. No Association Between Vitamin D Supplementation and Risk of Colorectal Adenomas or Serrated Polyps in a Randomized Trial.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2021
    Trial
  4. Trial
  5. Trial
  6. Article
  7. Impact of Diet on Colorectal Cancer Progression and Prevention: From Nutrients to Neoplasms.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Vitamin D and colon cancer.World journal of gastrointestinal oncology · 2014
    Review
  20. Plasma 25-Hydroxyvitamin DNutrition and cancer
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Elizabeth T JacobsUniversity of Arizona Cancer Center, University of Arizona, Tucson, Arizona; Division of Epidemiology, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona.
Elizabeth A Hibler
Peter Lance
Christine L Sardo
Peter W Jurutka
Arizona Science Center · USUniversity of Arizona · USArizona State University · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
WHEAT BRAN FIBER SUPPLEMENTS ON THE RECURRENCE OF COLONIC ADENOMASP01CA041108 · NCI · UNIVERSITY OF ARIZONA · PI HAMILTON, STANLEY R. · 1986 to 2009
$38.8M
SPORE in Gastrointestinal CancerP50CA095060 · NCI · UNIVERSITY OF ARIZONA · PI GERNER, EUGENE W · 2002 to 2012
$25.3M
Cancer Prevention and Control Translational ResearchR25CA078447 · NCI · UNIVERSITY OF ARIZONA · PI ALBERTS, DAVID SAMUEL · 1998 to 2014
$7.6M
Vitamin D Status, Genetic Variation in Vitamin D Signaling and Metabolism, and RiR01CA140285 · NCI · UNIVERSITY OF ARIZONA · PI JACOBS, ELIZABETH T, JURUTKA, PETER W · 2010 to 2014
$1.5M
NCI NIH HHS CA95060NCI NIH HHS P01 CA041108NCI NIH HHS P01CA41108NCI NIH HHS P30 CA023074NCI NIH HHS P30CA023074NCI NIH HHS P50 CA095060NCI NIH HHS R01 CA140285NCI NIH HHS R01CA140285NCI NIH HHS R25 CA078447
6 · The paper itself

Abstract

The relationship between the biomarker of vitamin D status, 25(OH)D, and the risk for colorectal neoplasia is suggestive but equivocal. Questions remain regarding whether there are differential associations between 25(OH)D and colorectal adenoma by gender, colorectal subsite or features of baseline and recurrent adenomas. We sought to investigate the relationship between 25(OH)D and both baseline and recurrent adenoma characteristics. Our study was conducted among 2,074 participants in a pooled population of two clinical intervention trials of colorectal adenoma recurrence. A cross-sectional analysis of 25(OH)D and baseline adenoma characteristics and a prospective study of recurrent adenomas and their characteristics were conducted. There was a statistically significant inverse association between the concentrations of 25(OH)D and the presence of three or more adenomas at baseline. Compared to participants with 25(OH)D levels of <20 ng/mL, the adjusted odds ratios (ORs) (95% condifdence intervals [CIs]) were 0.99 (0.70-1.41) for those with concentrations of ≥20 and <30 ng/mL, and 0.73 (0.50-1.06) among participants with levels of ≥30 ng/mL (p-trend = 0.05). Baseline villous histology was also significantly inversely related to 25(OH)D levels (p-trend = 0.04). Conversely, 25(OH)D concentrations were not associated with overall colorectal adenoma recurrence, with ORs (95% CIs) of 0.91 (0.71-1.17) and 0.95 (0.73-1.24; p-trend = 0.85). These findings support the concept that the relationship between vitamin D and colorectal neoplasia may vary by stage of adenoma development.

Indexed as

AdenomaAgedColorectal NeoplasmsCross-Sectional StudiesFemaleHumansMaleMiddle AgedNeoplasm StagingOdds RatioProspective StudiesVitamin D25-hydroxyvitamin DVitamin D25(OH)Dcolon cancercolorectal adenomavitamin D

Identifiers

PMID23754630
PMCPMC3797158
OpenAlexW2147860823

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.